FINAL REFUSAL - MAILED
mailed
on 17 Oct 2024
Last Applicant/ Owned by
788 Morris Turnpike, Floor 3
Short Hills
NJ
07078
Serial Number
98112787 filed on 02th Aug 2023
Registration Number
N/A
Correspondent Address
Alicia M. Passerin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EYE MEDICINALS
Providing an interactive website featuring technology that allows physicians to select and order custom compounded topical medications for patients, communicates orders to pharmacies, licenses the compounds and schedules shipping directly to the patient Providing an on-line searchable database featuring referrals in the field of ophthalmology
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Providing an interactive website featuring technology that allows physicians to select and order custom compounded topical medications for patients, communicates orders to pharmacies, licenses the compounds and schedules shipping directly to the patient
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Providing an on-line searchable database featuring referrals in the field of ophthalmology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98112787
Mark Type
No Service Mark
Attorney Docket Number
No 17910-031
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Oct 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 17th Oct 2024 | FINAL REFUSAL E-MAILED |
| 17th Oct 2024 | FINAL REFUSAL WRITTEN |
| 30th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 03rd Jul 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 03rd Jul 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 04th Apr 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 04th Apr 2024 | NON-FINAL ACTION WRITTEN |